Jordan’s Hikma Fights To Balance Arab Spring With Generics Decline
This article was originally published in PharmAsia News
Executive Summary
Jordan’s Hikma Pharmaceuticals is struggling to survive the events of the Arab Spring in its primary marketing area of the Middle East and North Africa, marked by an 11.3% decline in sales of generics.